Skip to main content
. 2023 Mar 21;14:1094339. doi: 10.3389/fendo.2023.1094339

Figure 3.

Figure 3

(A) The X-tile software of size of the largest metastatic LN for the prediction of persistent/recurrent disease vs long-term remission. (B) Patient frequency according to the size of the largest metastatic LN (the optimal cutoffs were 0.4cm and 1.4cm); (C) Kaplan Meier survival curves for different risk groups (P < 0.001).